JPMorgan reports higher-than-expected quarterly earnings, helped by narrowing losses on bad loans that allowed it to release $2 billion in reserves.
JPMorgan CEO Jamie Dimon reckons the bank will generate up to $50 billion in excess capital over the next three years. The veteran dealmaker should resist the temptation to go on a spending spree, writes Breakingviews columnist Antony Currie.
Sanofi-Aventis hopes to reach a takeover deal that would value Genzyme at around $76 per share, or some $20 billion, the French newspaper Le Figaro said.
A wave of split-offs could bolster what many already expect to be a big comeback in deal activity – fueled by cheap debt and record cash piles — this year.
“Hedge funds are crowding into more of the same trades these days, amplifying market swings during crises and unnerving investors,” the WSJ reports.








JPMorgan’s Jamie Dimon may have enough on his plate – for now.